Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2012 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.
Br J Cancer. 2012 Mar 13;106(6):1062-7. doi: 10.1038/bjc.2012.43. Epub 2012 Feb 21.
Br J Cancer. 2012.
PMID: 22353807
Free PMC article.
Clinical Trial.
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.
Schwartzberg LS, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani V, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn K, Kirshner JJ, Eisenberg P, Emanuelson R, Keaton M, Levine E, Medgyesy DC, Qamar R, Starr A, Ro SK, Lokker NA, Hudis CA.
Schwartzberg LS, et al. Among authors: medgyesy dc.
Clin Cancer Res. 2013 May 15;19(10):2745-54. doi: 10.1158/1078-0432.CCR-12-3177. Epub 2013 Feb 26.
Clin Cancer Res. 2013.
PMID: 23444220
Clinical Trial.
Item in Clipboard
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee.
Mieog JS, et al.
Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X. Epub 2012 Jan 20.
Lancet Oncol. 2012.
PMID: 22265698
Clinical Trial.
Item in Clipboard
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma.
Pazdur R, Medgyesy DC, Winn RJ, Dakhil SR, Moore DF Jr, Scalzo A, Hoff PM, Arbuck SG, Abbruzzese JL.
Pazdur R, et al. Among authors: medgyesy dc.
Invest New Drugs. 1998-1999;16(4):341-6. doi: 10.1023/a:1006248700232.
Invest New Drugs. 1998.
PMID: 10426669
Clinical Trial.
Item in Clipboard
Cite
Cite